Male Infertility Market Scope And Analysis

Report Code : TIPRE00007061
Category : Biotechnology

No. of Pages : 150

Buy Now

Male Infertility Market Scope, Growth, Size and Share by 2031

Buy Now

Male Infertility Market Report Scope

Report Attribute	Details
Market size in 2021	US$ 3.47 Billion
Market Size by 2031	US$ 5.48 Billion
Global CAGR (2023 - 2031)	4.6%
Historical Data	2021-2022
Forecast period	2023-2031
Segments Covered	By Test DNA Fragmentation Technique Oxidative Stress Analysis Microscopic Examination Sperm Agglutination Computer Assisted Semen Analysis Sperm Penetration Assay By Treatment Type Assisted Reproductive Technology and Varicocele Surgery Medication By Distribution Channel Hospitals Pharmacies Pharmacies and Drug Stores Online Pharmacies By End User Hospitals and Clinics Fertility Centers Research Institutes Other End Users
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	MERCK KGaA Sanofi Bayer AG Endo Pharmaceuticals Inc SCSA Diagnostics Inc Andrology Solutions Halotech DNA INTAS PHARMACEUTICALS LTD Cadila Pharmaceuticals Ltd Vitrolife

Male Infertility Market News and Recent Developments

The male infertility market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for male infertility:

Sidra Medicine has launched a new male infertility clinic as part of its expansion of private reproductive medicine services in Qatar. (Source: Sidra Medicine, Newsroom, 2022)
Merck, a leading science and technology company, today announced that the European Commission (EC) has granted Marketing Authorization (MA) for its new GONAL-f (follitropin alfa) 150 IU pen. This means Merck now offers an even more comprehensive range of best-in-class pens, supporting patients from the beginning to the end of their fertility stimulation cycle, when lower doses are required. (Source: Merck KGaA, Press Release, 2020)

Male Infertility Market Report Coverage and Deliverables

The “Male Infertility Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis
Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles